| __timestamp | Amneal Pharmaceuticals, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 4326000 |
| Thursday, January 1, 2015 | 109679000 | 226206000 |
| Friday, January 1, 2016 | 118757000 | 94391000 |
| Sunday, January 1, 2017 | 109046000 | 53821000 |
| Monday, January 1, 2018 | 230435000 | 35463000 |
| Tuesday, January 1, 2019 | 289598000 | 46456000 |
| Wednesday, January 1, 2020 | 326727000 | 71318000 |
| Friday, January 1, 2021 | 365504000 | 135256000 |
| Saturday, January 1, 2022 | 399700000 | 102708000 |
| Sunday, January 1, 2023 | 429675000 | 129620000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Amneal Pharmaceuticals, Inc. and ImmunityBio, Inc. from 2014 to 2023. Over this period, Amneal Pharmaceuticals consistently outpaced ImmunityBio in SG&A spending, with a peak in 2023 where their expenses were nearly 3.3 times higher. This trend highlights Amneal's aggressive market strategies and operational scale. Notably, Amneal's SG&A expenses grew by approximately 407% from 2014 to 2023, reflecting their expansion and increased market presence. In contrast, ImmunityBio's expenses, while more volatile, showed a significant spike in 2015, indicating strategic investments or restructuring efforts. This financial insight provides a window into the operational priorities and growth trajectories of these pharmaceutical giants.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and Merus N.V.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
Amneal Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Vericel Corporation and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: ImmunityBio, Inc. vs Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.